Sumitomo Mitsui Trust Group
UTHR icon

Sumitomo Mitsui Trust Group’s United Therapeutics UTHR Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$52.6M Sell
88,637
-3,519
-4% -$1.75M 0.03% 427
2025
Q4 		$44.9M Sell
92,156
-2,546
-3% -$1.19M 0.03% 498
2025
Q3 		$39.7M Sell
94,702
-5,546
-6% -$1.87M 0.02% 532
2025
Q2 		$28.8M Buy
100,248
+2,521
+3% +$753K 0.02% 592
2025
Q1 		$30.1M Buy
97,727
+4,054
+4% +$1.39M 0.02% 574
2024
Q4 		$33.1M Sell
93,673
-5,736
-6% -$2.11M 0.02% 558
2024
Q3 		$35.6M Sell
99,409
-425
-0.4% -$144K 0.02% 546
2024
Q2 		$31.8M Sell
99,834
-1,208
-1% -$320K 0.02% 546
2024
Q1 		$23.2M Buy
101,042
+338
+0.3% +$76.3K 0.02% 685
2023
Q4 		$22.1M Buy
100,704
+640
+0.6% +$148K 0.02% 686
2023
Q3 		$22.6M Buy
100,064
+560
+0.6% +$129K 0.02% 672
2023
Q2 		$22M Sell
99,504
-16,383
-14% -$3.63M 0.02% 692
2023
Q1 		$26M Buy
115,887
+113,987
+5,999% +$28.1M 0.02% 673
2022
Q4 		$528K Sell
1,900
-800
-30% -$202K ﹤0.01% 1099
2022
Q3 		$565K Buy
2,700
+500
+23% +$112K ﹤0.01% 1097
2022
Q2 		$518K Buy
2,200
+500
+29% +$102K ﹤0.01% 1126
2022
Q1 		$305K Sell
1,700
-200
-11% -$38.1K ﹤0.01% 1139
2021
Q4 		$411K Buy
+1,900
New +$373K ﹤0.01% 1108
2021
Q3 		– Sell
-1,900
Closed -$341K – 1214
2021
Q2 		$341K Sell
1,900
-1,400
-42% -$267K ﹤0.01% 1137
2021
Q1 		$552K Sell
3,300
-900
-21% -$150K ﹤0.01% 1073
2020
Q4 		$638K Sell
4,200
-9,303
-69% -$1.22M ﹤0.01% 1049
2020
Q3 		$1.36M Buy
+13,503
New +$1.48M ﹤0.01% 936
2020
Q2 		– Sell
-13,434
Closed -$1.27M – 1147
2020
Q1 		$1.27M Buy
+13,434
New +$1.28M ﹤0.01% 913
2019
Q2 		– Sell
-172,077
Closed -$20.2M – 1035
2019
Q1 		$20.2M Buy
172,077
+1,091
+0.6% +$127K 0.02% 633
2018
Q4 		$18M Buy
170,986
+36,544
+27% +$4.24M 0.02% 616
2018
Q3 		$17.2M Buy
134,442
+919
+0.7% +$114K 0.02% 636
2018
Q2 		$15.1M Buy
133,523
+8,160
+7% +$897K 0.02% 646
2018
Q1 		$14.1M Buy
125,363
+933
+0.7% +$119K 0.02% 637
2017
Q4 		$18.4M Buy
124,430
+3,621
+3% +$460K 0.02% 609
2017
Q3 		$14.2M Sell
120,809
-2,207
-2% -$282K 0.02% 623
2017
Q2 		$16M Buy
123,016
+2,762
+2% +$345K 0.02% 616
2017
Q1 		$16.3M Sell
120,254
-2,970
-2% -$450K 0.03% 590
2016
Q4 		$17.7M Buy
123,224
+910
+0.7% +$116K 0.03% 575
2016
Q3 		$14.4M Sell
122,314
-1,095
-0.9% -$132K 0.02% 602
2016
Q2 		$13.1M Sell
123,409
-19,275
-14% -$2.15M 0.02% 602
2016
Q1 		$15.9M Sell
142,684
-2,202
-2% -$279K 0.03% 579
2015
Q4 		$23M Sell
144,886
-2,946
-2% -$429K 0.04% 475
2015
Q3 		$19.4M Buy
147,832
+28,416
+24% +$4.56M 0.04% 519
2015
Q2 		$20.8M Buy
+119,416
New +$21.5M 0.04% 528

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Sumitomo Mitsui Trust Group's UTHR Position: Q1 2026 in Review

Sumitomo Mitsui Trust Group reduced its United Therapeutics (UTHR) stake by 3.8% in Q1 2026, selling an estimated $1.75M and leaving 88,637 shares worth $52.6M. The position accounts for 0.03% of the portfolio, ranked #427.

Sumitomo Mitsui Trust Group first reported a position in UTHR in Q2 2015 and has held it in 39 quarters since. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Sumitomo Mitsui Trust Group held 88,637 shares of United Therapeutics worth $52.6M as of Q1 2026.
  • Sumitomo Mitsui Trust Group sold 3,519 United Therapeutics shares in Q1 2026, an estimated $1.75M.
  • United Therapeutics made up 0.03% of Sumitomo Mitsui Trust Group's portfolio in Q1 2026, its #427 holding.
  • Sumitomo Mitsui Trust Group first reported a position in United Therapeutics in Q2 2015 and has held it in 39 quarters since.
  • 850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q1 2026, filed 30 Apr 2026.